Zymeworks (ZYME) Misses Q3 EPS by 26c

Zymeworks (NASDAQ: ZYME) reported Q3 EPS of ($0.26). Revenue for the quarter came in at $27.6 million.

For earnings history and earnings-related data on Zymeworks (ZYME) click here.

You May Also Be Interested In

• Regency Centers (REG) Tops Q2 EPS by 2c
• Veraxa Biotech AG (VRXA) files for 25M share offering by selling stockholders
• Heritage Global to wind down specialty lending unit, expects material charge